BNP Paribas Financial Markets
DRTX

BNP Paribas Financial Markets’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,055
Closed -$13.4K – 4087
2014
Q3 		$13.4K Buy
1,055
+1,018
+2,751% +$15.2K ﹤0.01% 3433
2014
Q2 		$630 Buy
+37
New +$551 ﹤0.01% 3547
2014
Q1 		– Sell
-168
Closed -$2.15K – 4175
2013
Q4 		$2.15K Buy
+168
New +$1.76K ﹤0.01% 3628

BNP Paribas Financial Markets's DRTX Position: Q4 2014 in Review

BNP Paribas Financial Markets sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 1,055 shares — an estimated $13.4K sold.

BNP Paribas Financial Markets first reported a position in DRTX in Q4 2013 and held it in 3 quarters. The position peaked at $13.4K in Q3 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • BNP Paribas Financial Markets reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,055 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $13.4K.
  • BNP Paribas Financial Markets first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $13.4K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2014, filed 11 Feb 2015.